SEC
WST icon

Seven Eight Capital’s West Pharmaceutical WST Stock Holding History

Seven Eight Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,449
Closed -$5.79M – 852
2023
Q4 		$5.79M Buy
16,449
+15,125
+1,142% +$5.35M 0.67% 32
2023
Q3 		$497K Buy
+1,324
New +$512K 0.06% 393
2022
Q4 		– Sell
-4,430
Closed -$1.09M – 657
2022
Q3 		$1.09M Buy
+4,430
New +$1.35M 0.22% 141
2021
Q2 		– Sell
-4,400
Closed -$1.25M – 727
2021
Q1 		$1.25M Hold
4,400
– – 0.29% 128
2020
Q4 		$1.25M Buy
+4,400
New +$1.23M 0.28% 129
2020
Q2 		– Sell
-2,300
Closed -$350K – 585
2020
Q1 		$350K Sell
2,300
-7,900
-77% -$1.22M 0.09% 282
2019
Q4 		$1.53M Sell
10,200
-4,000
-28% -$582K 0.08% 373
2019
Q3 		$2.01M Buy
+14,200
New +$1.96M 0.11% 286
2019
Q2 		– Sell
-16,500
Closed -$1.82M – 758
2019
Q1 		$1.82M Buy
+16,500
New +$1.72M 0.1% 266
2018
Q1 		– Sell
-22,300
Closed -$2.2M – 551
2017
Q4 		$2.2M Buy
+22,300
New +$2.19M 0.22% 161
2017
Q3 		– Sell
-13,400
Closed -$1.27M – 643
2017
Q2 		$1.27M Buy
13,400
+9,900
+283% +$911K 0.18% 179
2017
Q1 		$286K Buy
3,500
+100
+3% +$8.36K 0.06% 338
2016
Q4 		$288K Sell
3,400
-12,400
-78% -$975K 0.06% 363
2016
Q3 		$1.18M Buy
15,800
+13,400
+558% +$1.06M 0.34% 102
2016
Q2 		$182K Buy
2,400
+2,357
+5,481% +$172K 0.06% 337
2016
Q1 		$3K Buy
+43
New +$2.59K ﹤0.01% 508

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Seven Eight Capital's WST Position: Q1 2024 in Review

Seven Eight Capital sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 16,449 shares — an estimated $5.79M sold.

Seven Eight Capital first reported a position in WST in Q1 2016 and held it in 16 quarters. The position peaked at $5.79M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Seven Eight Capital reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Seven Eight Capital sold 16,449 West Pharmaceutical shares in Q1 2024, an estimated $5.79M.
  • Seven Eight Capital first reported a position in West Pharmaceutical in Q1 2016 and held it in 16 quarters.
  • Seven Eight Capital's West Pharmaceutical position peaked at $5.79M in Q4 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.